US FDA Approves Pfizer’s Maternal RSV Vaccine To Protect Infants
US FDA Approves Pfizer’s Maternal RSV Vaccine To Protect Infants: The U.S. Food and Drug Administration (FDA) recently grants approval to the first vaccine created to forestall (Respiratory Syncytial Virus) RSV-associated LRTD (Lower respiratory tract disease) and severe cases in infants spanning birth to 6 months. This momentous decision is fostering optimism among parents and […]
US FDA Approves Pfizer’s Maternal RSV Vaccine To Protect Infants Read More »










